Infant Phototherapy Market Outlook
Market Overview
The Global Infant Phototherapy Device Market is on a steady growth trajectory, with its valuation reaching US$ 96.44 Million in 2023. Fueled by technological advancements and increasing demand for neonatal care, the market is forecasted to expand at a CAGR of 3.89% between 2024 and 2032, reaching US$ 135.97 Million by the end of the forecast period, according to Renub Research.
Phototherapy devices play a crucial role in treating infant jaundice, a common condition among newborns. By leveraging specific wavelengths of light, these devices convert bilirubin—the substance responsible for jaundice—into a water-soluble form that the body can excrete naturally. This non-invasive treatment is pivotal for neonatal health, especially for preterm and low-birth-weight infants.
Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=infant-phototherapy-device-market-p.php
Infant Population and Birth Trends
Population trends directly impact the demand for phototherapy devices, given the high prevalence of jaundice among newborns:
- United States:
The CDC reported 3,664,292 births in 2021, with a fertility rate of 56.3 births per 1,000 women aged 15-44. Preterm births, a significant contributor to neonatal jaundice cases, also remain a concern. - India:
India records the highest number of annual births globally, with an estimated 24 million births annually, as per the National Population Register. This vast birth rate drives the demand for neonatal care technologies, including phototherapy devices. - China:
In 2023, China recorded 9.02 million births, reflecting 6.39 births per 1,000 people, according to the National Bureau of Statistics. The relaxation of the one-child policy further emphasizes the need for enhanced neonatal care infrastructure. - Europe:
In countries like France, where 678,000 babies were born in 2023 (fertility rate: 1.68 children per woman), phototherapy adoption continues to grow with advanced healthcare systems supporting neonatal health.
Technological Innovations in Phototherapy
Technological advancements are driving market expansion through improved treatment efficacy and accessibility:
- Portable Phototherapy Units: Innovations like portable devices allow treatment at home without disrupting parent-infant bonding.
- Example: The BilliTouch phototherapy blanket, launched by Motif Medical in 2021, is lightweight, battery-powered, and ideal for use in hospitals or homes.
Related Report:
Clinical Trial Supplies Market
Regional Insights
North America
As a leader in early adoption, North America has set the benchmark in phototherapy device usage due to its advanced healthcare systems and increased prevalence of neonatal jaundice.
- The CDC reported that 1 in 10 babies born in the U.S. in 2022 were preterm, highlighting the critical role of phototherapy devices.
- Healthcare advancements and stringent treatment protocols further reinforce North America’s dominance in this market.
Asia-Pacific
The Asia-Pacific region, led by India and China, is witnessing robust growth driven by high birth rates, rising awareness, and government initiatives to improve neonatal care.
Key Players and Recent Developments
The global infant phototherapy device market is competitive, with significant contributions from prominent companies:
- Drägerwerk AG & Co. KGaA: Developing intelligent intensive care units with cutting-edge phototherapy solutions.
- NeoLight: Expanded its neonatal care portfolio with the acquisition of Phoenix Technology Group in 2021.
- GenWorks: Introduced the Billicare non-invasive bilirubin analyzer in 2022.
Market Segmentation
By Light Source
- Fluorescent Lamps
- Light Emitting Diodes (LEDs)
- Quartz Halogen Lamps
- Gas Discharge Tubes
By Configuration
- Mobile Devices
- Fixed Devices
By End User
- Hospitals
- Neonatal Clinics
By Country
- North America (United States, Canada)
- Europe (France, Germany, Italy, Spain, United Kingdom, etc.)
- Asia-Pacific (China, Japan, India, etc.)
- Latin America (Brazil, Mexico, Argentina)
- Middle East & Africa (Saudi Arabia, UAE, South Africa)
About Us – Renub Research
Renub Research is a premier Market Research and Advisory company with over 15 years of experience in Business-to-Business Global Market Research, Business Surveys, and Management Consulting. We provide a wide range of specialized business research services designed to help organizations make informed decisions and achieve their highest potential.
We work closely with our clients to understand the challenges they face and offer actionable insights to address these challenges. Our services are aimed at identifying the necessary changes and strategic adjustments needed for companies to succeed in today’s competitive market. Our clients include leading organizations from a wide range of industries such as Healthcare, Travel & Tourism, Food & Beverages, Power & Energy, Information Technology, Telecommunications & Internet, Chemicals, Logistics & Automotive, Consumer Goods & Retail, Building & Construction, and Agriculture.
At Renub Research, we provide our clients with detailed and accurate market data to support decision-making based on both information and knowledge. Our firm is recognized for delivering comprehensive industry solutions that aid consultants, bankers, and executives in formulating effective business strategies and making sound management decisions.
Our team comprises skilled professionals with expertise across various fields, including finance, marketing, human resources, biotechnology, pharmaceuticals, IT, environmental science, and more. The insights derived from our studies form the foundation for crucial management decisions, such as strategies, organizational structure, technology adoption, and mergers and acquisitions.
We take pride in supporting top global players, providing not only IT solutions but also comprehensive market trend analysis and opportunities. Our research reports offer critical tools for managers in today’s competitive global economy, featuring information and insights, analysis and understanding, as well as forecasts and estimations to guide decision-making
Sandy D